Three leading centers—San Francisco, Boston and San Diego—still account for almost two-thirds of all biotech venture capital after a quarter century. In innovative, knowledge-based industries, there are huge competitive advantages to being located in a cluster of firms, workers, financiers and researchers. The evidence shows that leadership in biotechnology has been locked in to a handful of leading locations, and their dominance persists, de…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.